Vemlidy 25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FNP4W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,367
Award facts
- Contract value 100% obligated
- $8,367.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Vemlidy 25 mg tablets (quantity: 30 units) with a ceiling value of $8,367.01. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of December 10, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The DLA Troop Support Medical contract vehicle enables AmerisourceBergen to supply pharmaceutical products and medical commodities to support defense healthcare requirements globally, including services to the Defense Health Agency and U.S. Coast Guard. The current award of Vemlidy, an antiviral hepatitis B medication, exemplifies the company's role in supplying specialized pharmaceutical products through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FNP4W?
SPE2DR26FNP4W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FNP4W worth?
The government has obligated $8,367 on SPE2DR26FNP4W.
Is contract SPE2DR26FNP4W an order under another contract?
Yes. SPE2DR26FNP4W is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNP4W competed?
The extent of competition for SPE2DR26FNP4W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award